[Federal Register Volume 60, Number 16 (Wednesday, January 25, 1995)]
[Notices]
[Page 4920]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1805]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advisory Committee on Immunization Practices; Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices.
    Times and Dates: 8:30 a.m.-6:30 p.m., February 9, 1995. 8:15 
a.m.-4:45 p.m., February 10, 1995.
    Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents.
    Matters to be Discussed: The committee will discuss 
recommendations for prevention of hepatitis A: Hepatitis A vaccine 
and immune globulin; revised recommendations for hepatitis B 
vaccination; update on varicella vaccine; status on principles and 
guidelines for combination products; vaccines for children (VFC): 
influenza vaccine in VFC, hepatitis B for adolescents in VFC, 
hepatitis A, MMR2--expanded use in VFC; pneumococcal polysaccharide 
vaccine; adolescent vaccination; poliomyelitis prevention; 
influenza: 1995-96 influenza vaccine strain selection, 1995-96 
influenza vaccine and antiviral recommendations, influenza-
associated morbidity during pregnancy, assessment of BBS risk 
associated with 1993-94 and 1994-95 influenza vaccination, optimal 
needle length for intramuscular injection into the deltoid, national 
estimates of influenza vaccination rates; update on meningococcal 
recommendation; report of a meeting regarding conflicting 
immunization guidelines and harmonization of the Advisory Committee 
on Immunization Practices/American Academy of Pediatrics 
recommendations with the Food and Drug Administration labeling; 
update on simplification; progress towards 1996 disease reduction 
goals; recommendations for immunization linkage with the women's, 
infants, and children program; vaccine safety; an update on the 
Injury Compensation Program; an update on the National Vaccine 
Program; and a presentation on acellular pertussis. Other matters of 
relevance among the committee's objectives may be discussed.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Gloria A. Kovach, Committee 
Management Specialist, CDC (1-B72), 1600 Clifton Road, NE., Mailstop 
A20, Atlanta, Georgia 30333, telephone 404/639-3851.
    Dated: January 18, 1995.
William H. Gimson,
Acting Associate Director for Policy Coordination, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-1805 Filed 1-24-95; 8:45 am]
BILLING CODE 4163-18-M